PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

The drug is a recombinant version of the enzyme ... of glycogen to toxic levels that damage muscle cells. Sanofi's Genzyme rare diseases division already sells another enzyme replacement therapy ...

Small-molecule drug development also has tapped into the IL-23 component ... Ortho Dermatologics, Pfizer, Regeneron, Sanofi ...

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of Jeff ...

Correspondence to Professor Maria A Rocca, Neuroimaging Research Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milano 20132, Italy; rocca.mara{at}hsr.it PRLs are considered relatively ...

Liquidia Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

She was speaking after two men were convicted of being involved in the killing of a 37-year-old drug "runner" Dean Fountaine, from Leighton Buzzard. Peter Janoski, 44, has been found guilty of murder ...